Abstract:Acute myeloid leukemia (AML) is a high mortality and recurrence rates hematologic malignancy. Thus, whatever early detection or subsequent visit are both of high significance. Traditional AML diagnosis is conducted via peripheral blood (PB) smear and bone marrow (BM) aspiration. But BM aspiration is a painful burden for patients especially in early detection or subsequent visit. Herein, the use of PB to evaluate and identify the leukemia characteristics will be an attractive alternative source for early detection or subsequent visit. Fourier transform infrared spectroscopy (FTIR) is a time- and cost-effective approach to reveal the disease-related molecular features and variations. However, to the best of our knowledge, there is no attempts using infrared spectroscopic signatures of PB to replace BM for identifying AML. In this work, we are the first to develop a rapid and minimally invasive method to identify AML by infrared difference spectrum (IDS) of PB with only 6 characteristic wavenumbers. We dissect the leukemia-related spectroscopic signatures of three subtypes of leukemia cells (U937, HL-60, THP-1) by IDS, revealing biochemical molecular information about leukemia for the first time. Furthermore, the novel study links cellular features to complex features of blood system which demonstrates the sensitivity and specificity with IDS method. On this basis, BM and PB of AML patients and healthy controls were provided to parallel comparison. The IDS of BM and PB combined with principal component analysis method revealing that the leukemic components in BM and PB can be described by IDS peaks of PCA loadings, respectively. It is demonstrated that the leukemic IDS signatures of BM can be replaced by the leukemic IDS signatures of PB. In addition, the IDS signatures of leukemia cells are reflected in PB of AML patients with peaks of 1629, 1610, 1604, 1536, 1528 and 1404 cm −1 for the first time as well. To this end, we access the leukemic signatures of IDS peaks to compare the PB of AMLs and healthy controls. It is confirmed that the leukemic components can be detected from PB of AML and distinguished into positive (100%) and negative (100%) groups successfully by IDS classifier which is a novel and unique spectral classifier. This work demonstrates the potential use of IDS as a powerful tool to detect leukemia via PB which can release subjects' pain remarkably.

Spatial-spectral Identification of Abnormal Leukocytes Based on Microscopic Hyperspectral Imaging Technology

Fusion of Color Correction and HSV Segmentation Techniques for Automated Segmentation of Acute Lymphoblastic Leukemia

A Segmentation Method Based on HMRF for the Aided Diagnosis of Acute Myeloid Leukemia

A robust classification of acute lymphocytic leukemia-based microscopic images with supervised Hilbert-Huang transform

Identification of acute myeloid leukemia by infrared difference spectrum of peripheral blood

Detection of acute lymphoblastic leukemia using image segmentation and data mining algorithms

Superpixel-based Spectral Classification for the Detection of Head and Neck Cancer with Hyperspectral Imaging

Hybrid adversarial-discriminative network for leukocyte classification in leukemia

Weakly Supervised Ternary Stream Data Augmentation Fine-Grained Classification Network for Identifying Acute Lymphoblastic Leukemia

ResRandSVM: Hybrid Approach for Acute Lymphocytic Leukemia Classification in Blood Smear Images

A Hybrid Feature Fusion Deep Learning Framework for Leukemia Cancer Detection in Microscopic Blood Sample Using Gated Recurrent Unit and Uncertainty Quantification

Deep Learning Algorithms for Early Diagnosis of Acute Lymphoblastic Leukemia

Identification and Staging of B-Cell Acute Lymphoblastic Leukemia Using Quantitative Phase Imaging and Machine Learning

Segmentation of White Blood Cell from Acute Lymphoblastic Leukemia Images Using Dual-Threshold Method

Blood Cancer Diagnosis Using Hyperspectral Imaging Assisted with Forward Searching Method and Machine Learning

Red Blood Cell Count Automation Using Microscopic Hyperspectral Imaging Technology

A survey on automated detection and classification of acute leukemia and WBCs in microscopic blood cells

Deep learning model for differentiating acute myeloid and lymphoblastic leukemia in peripheral blood cell images via myeloblast and lymphoblast classification

Immune-based abnormal sample identification for spectral quantitative analysis

Support Vector Machine and Morphological Processing Algorithm for Red Blood Cell Identification

Deep learning-based light scattering microfluidic cytometry for label-free acute lymphocytic leukemia classification